Girish Aras
About
In The Last Decade
Girish Aras
20 papers receiving 907 citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Immunology 730
- Dermatology 360
- Rheumatology 178
- Physiology 169
- Hematology 133
Countries citing papers authored by Girish Aras
This map shows the geographic impact of Girish Aras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Girish Aras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Girish Aras more than expected).
Fields of papers citing papers by Girish Aras
This network shows the impact of papers produced by Girish Aras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Girish Aras. The network helps show where Girish Aras may publish in the future.
Co-authorship network of co-authors of Girish Aras
This figure shows the co-authorship network connecting the top 25 collaborators of Girish Aras. A scholar is included among the top collaborators of Girish Aras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Girish Aras. Girish Aras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 13 | |
| 3 | Open-Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With Apremilast. | 5 |
| 4 | 14 | |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 9 | |
| 8 | 51 | |
| 9 | 31 | |
| 10 | Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis breakdown → | 729 |
| 11 | A randomized, multi-center, blinded, placebo-controlled study with an open-label run-in period to evaluate anakinra in polyarticular-course juvenile rheumatoid arthritis | 4 |
| 12 | 15 | |
| 13 | 3 | |
| 14 | 14 | |
| 15 | 7 | |
| 16 | 6 | |
| 17 | 0 | |
| 18 | 2 | |
| 19 | 4 | |
| 20 | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.